Filing Details

Accession Number:
0001555280-25-000095
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-11 17:15:24
Reporting Period:
2025-02-08
Accepted Time:
2025-02-11 17:15:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1555280 Zoetis Inc. ZTS Pharmaceutical Preparations (2834) 460696167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1567878 Roxanne Lagano C/O Zoetis Inc.
10 Sylvan Way
Parsippany NJ 07054
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-02-08 597 $0.00 15,719 No 4 M Direct
Common Stock Disposition 2025-02-08 226 $171.43 15,493 No 4 F Direct
Common Stock Acquisiton 2025-02-08 1,404 $0.00 16,897 No 4 M Direct
Common Stock Disposition 2025-02-08 464 $171.43 16,433 No 4 F Direct
Common Stock Disposition 2025-02-11 326 $171.18 16,107 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2025-02-08 598 $0.00 598 $0.00
Common Stock Restricted Stock Unit Disposition 2025-02-08 1,404 $0.00 1,404 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
597 No 4 M Direct
0 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 812 Indirect 401(k)
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Restricted Stock Unit $0.00 1,074 1,074 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
1,074 1,074 Direct
Footnotes
  1. Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.
  2. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.
  3. The Price reported in Table I, Column 4 is the price at which these shares were sold in a single transaction.
  4. Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2024.
  5. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
  6. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
  7. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 8, 2023; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  8. Not applicable.
  9. Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
  10. Each RSU vests and is settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022.
  11. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.